SCHEMBL23937901

SCHEMBL23937901

Cc1nn(O)c2c1CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PARP1 P09874 1/20 0.32
POLB P06746 2/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
BRD4 O60885 1/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 1/20 0.31
CYP1A2 P05177 1/20 0.31
GAA P10253 1/20 0.31
HTR6 P50406 2/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937886 0.96 KDM4E (0.44) KDM4EL3MBTL1NPC1ALDH1A1HPGD
SCHEMBL14752475 0.76 PARP1 (0.43) KDM4EL3MBTL1NPC1ALDH1A1HPGD
SCHEMBL14752431 0.74 PARP1 (0.42) KDM4EL3MBTL1NPC1ALDH1A1HPGD
SCHEMBL20631147 0.74 LMNA (0.33) KMT2ALMNAGAA
SCHEMBL20631125 0.74 GAA (0.39) KMT2APOLBCYP1A2GAAHTR6
SCHEMBL25772021 0.72 KDM4E (0.40) KDM4EL3MBTL1NPC1ALDH1A1HPGD
SCHEMBL25796237 0.72 KDM4E (0.40) KDM4EL3MBTL1NPC1ALDH1A1HPGD
SCHEMBL23937897 0.72 PARP1 (0.33) PARP1
SCHEMBL20631124 0.72 LMNA (0.36) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL20631137 0.72 GRIA2 (0.38) L3MBTL1KMT2APOLBMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed